MINNEAPOLIS, Aug. 13, 2025 /PRNewswire/ — A recent study published in the Journal of the Society for Cardiovascular Angiography & Interventions (JSCAI) highlights the effectiveness of the EggNest™ Complete radiation shielding system, demonstrating its superior ability to protect all…
Radiology
AngioDynamics Announces Publication of PRESERVE Study of NanoKnife® System for Prostate Tissue Ablation in European Urology
Peer-reviewed findings demonstrate high disease control and quality-of-life preservation, supporting shift toward focal therapy in prostate treatment LATHAM, N.Y.–(BUSINESS WIRE)–AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of […]
Remedy Logic and RADIN Health® Execute Partnership Agreement
NEW YORK, July 21, 2025 /PRNewswire/ — Remedy Logic, a pioneer in radiology artificial intelligence, today announced it has signed a partnership agreement with RADIN Health® a leading cloud-based, all-in-one, RIS, PACS, Dictation AI®, and Select® workflow management solution, further…
Piccolo Medical, Inc. Receives FDA Clearance for 2nd Generation SmartPICC® technology
SAN FRANCISCO, July 16, 2025 /PRNewswire/ — Piccolo Medical, Inc. (Piccolo), a leading innovator in vascular access technology, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its next-generation SmartPICC® Stylet and PM2+™…
Sirtex Medical’s SIR-Spheres® Y-90 Resin Microspheres Receive FDA Approval for the Treatment of Unresectable Hepatocellular Carcinoma
Expanded indication makes SIR-Spheres® the first and only radioembolization therapy in the U.S. approved to treat both unresectable hepatocellular carcinoma and metastatic colorectal cancer WOBURN, Mass., July 7, 2025 /PRNewswire/ — Sirtex Medical (“Sirtex”), a leading manufacturer of…
UFE Doesn’t Remove Fibroids–Here’s What Women Aren’t Being Told
WASHINGTON, June 25, 2025 /PRNewswire/ — Every year, thousands of women are steered toward a fibroid treatment that doesn’t actually remove fibroids. Uterine Fibroid Embolization (UFE) may sound minimally invasive but it doesn’t remove fibroids; it just shrinks them, slightly, often with…
MultiFunctional Imaging Announces Journal Of Nuclear Cardiology Publication Detailing Rapid Myocardial Perfusion Imaging
Data demonstrates MFI’s propriety software enables 15 minute immediate back-to-back Rest- Stress scanning with Flyrcadoä radiotracer SOUTH OGDEN, UT – June 20, 2025 –- MultiFunctional Imaging LLC (MFI) today announced the publication of data submitted to the Journal of Nuclear Cardiology (JNC), a leading peer-reviewed journal. The study validates MFI’s […]
RADPAIR and Lifetrack Announce Strategic Partnership to Revolutionize Radiology Workflow and Global Access
KNOXVILLE, Tenn., June 18, 2025 /PRNewswire/ — RADPAIR, a leading innovator in AI-powered radiology automation, and Lifetrack, a next-generation medical imaging platform, have announced a strategic partnership aimed at transforming radiology workflow, reporting efficiency, and global…
ITM to Provide COMPETE Trial Insights at SNMMI 2025 Annual Meeting in Oral Presentation and Satellite Symposium
Garching / Munich, Germany, June 13, 2025 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced that it will provide further analysis from its recently completed Phase 3 COMPETE trial in an oral presentation and Satellite Symposium at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting, held from June 21 – June 24, 2025 in New Orleans, Louisiana. Details of the Oral PresentationThe data will be presented by Dr. Thomas A. Hope, MD, Chief of Nuclear Medicine at the San Francisco VA Medical Center and Vice Chair of Clinical Operations and Strategy in the Department of Radiology at UCSF in an oral presentation titled, “Predicting the [177Lu]Lu-edotreotide uptake in tumors using pre-therapeutic Ga-68 PET/CT imaging”, on Sunday, June 22 in the Neuroendocrine – Oncology Clinical Diagnosis and Therapy session from 3:30 – 4:45 pm CDT. The presentation will provide an analysis on the 177Lu-edotreotide tumor uptake and its predictability based on pre-therapeutic SSTR PET/CT imaging and other factors.
CIVIE Launches RadPod, an AI-Empowered On-Demand Radiology Reading Platform
DALLAS–(BUSINESS WIRE)–CIVIE, a leading healthcare technology and services company, today announces the official launch of RadPod, an AI-driven, on-demand radiology platform designed to transform how, when and where radiologists work. RadPod was developed to align the interests of radiologists, hospital systems and the latest in healthcare technology to ensure the practice of […]


